Theriva Corp (TOVX) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti

Synthetic Biologics (TOVX) korporativ emblemasi va logotipi

Theriva Biologics, Inc. (TOVX) uchun narxlar grafigi, operatsion modeli virusli vektorlarni ishlab chiqish va klinik sinovlar uchun tashqi pudratchilarga tayanadigan aktivning narxlar dinamikasini aks ettiradi. Joriy ko'rsatkich -0.60 darajasida turibdi. Theriva Biologics, Inc. (TOVX) mikrobiom himoyasi va o'simtaga qarshi agentlarni ishlab chiqmoqda. Asosiy o'sish omillari orasiga VCN-01 tadqiqoti natijalari, kombinatsiyalangan terapiyaning samaradorligi va biznesni yirik investorga sotish imkoniyati kiradi.

TOVX therivabio.com: Narx-foyda koeffitsiyenti 28.04.2023 - 18.11.2026 oraligʻida

Theriva Biologics, Inc. kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning har tomonlama tahlili:TOVX Synthetic Biologics
Theriva Biologics, Inc. ishlab chiqargan mahsulot

Analitik emitentning kredit sifatini bozor kutuvlari prizmasi orqali baholaydi. Theriva Biologics, Inc. (TOVX) kompaniyasida tijorat mahsulotlarining yo'qligi uning hozirgi investitsiyalarga asoslangan onkologik ishlanmalar bosqichida ekanligini tasdiqlaydi. P/E baholash ko'rsatkichi aksiya narxini foydaga bo'lish orqali sof foydaning bir birlik xarajatini aks ettiradi. Ushbu ko'rsatkichning tendentsiyasi spekulyativ talab va haqiqiy kapital samaradorligi o'rtasidagi muvozanatni ochib beradi. Grafikdagi keskin tebranishlar aktivning tartibga soluvchi xatarlarga yuqori sezgirligidan dalolat beradi.

Raqobatdosh kompaniyalar

Kapitalizatsiyaning foydaga nisbati ImmunityBio IBRX|P/E multiplikatori IMCR|Janux Therapeutics (JANX) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Arcus Biosciences Inc - Narx-foyda koeffitsiyenti|Zymeworks (ZYME) - Kapitalizatsiyaning foydaga nisbati|TNGX: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati IOVA (Iovance Biotherapeutics, Inc.)|IMTX: P/E multiplikatori|XNCR - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati compasstherapeutics.com|Narx-foyda koeffitsiyenti replimune.com (REPL)|Narxning foydaga nisbati Lyell (LYEL)|Narx-foyda koeffitsiyenti Innate Pharma, S.A. IPHA|Pyxis Oncology Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori Compugen Ltd. CGEN|IOBT - Narxning foydaga nisbati|STRO (sutrobio.com) - Narx-foyda multiplikatori|MiNK Therapeutics, Inc (INKT) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Werewolf Therapeutics (HOWL)|Narx-foyda koeffitsiyenti IMMX|ALXO - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|P/E multiplikatori CUE|Bozor narxining sof foydaga nisbati PDSB|P/E multiplikatori SONN (Sonnet BioTherapeutics)|Kompaniya qiymatining sof foydaga nisbati MAIA|liminatuspharma.com - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati LAVA Therapeutics|NextCure, Inc. (NXTC) - Narxning foydaga nisbati|Leap Therapeutics Inc - Kompaniya qiymatining sof foydaga nisbati|INTS (Intensity Tx) - P/E multiplikatori|P/E multiplikatori senseibio.com|Narxning foydaga nisbati gritstonebio.com (GRTS)|P/E multiplikatori Kineta Bio (KA)|NexImmune Inc - Narx-foyda koeffitsiyenti|turnstonebio.com (TSBX) - Kapitalizatsiyaning foydaga nisbati|VCNX: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati HARP (Harpoon Therapeutics, Inc.)